VitaNova Life Sciences (VNOV) Other Accumulated Expenses (2019 - 2025)

VitaNova Life Sciences (VNOV) has 5 years of Other Accumulated Expenses data on file, last reported at $3951.0 in Q4 2025.

• Quarterly Other Accumulated Expenses rose 338.03% year-over-year to $3951.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $3951.0 (up 338.03% YoY) and the FY2025 annual result came in at $820.0, down 90.12% from the prior year.
• Other Accumulated Expenses advanced to $3951.0 in Q4 2025, from $1226.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $28563.0 in Q2 2021 to a low of $820.0 in Q2 2025.
• A 3-year average of $5713.1 and a median of $2795.0 in 2025 frame the typical range for Other Accumulated Expenses.
• The widest YoY moves for Other Accumulated Expenses: up 338.03% in 2025, down 90.12% in 2025.
• Tracing VNOV's Other Accumulated Expenses over 3 years: stood at $28563.0 in 2021, then sank by 96.84% to $902.0 in 2024, then soared by 338.03% to $3951.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $3951.0 (Q4 2025), $1226.0 (Q3 2025), and $820.0 (Q2 2025), per Business Quant data.